MedPath

Practice Based Nutrition Intervention

Not Applicable
Completed
Conditions
Type 2 Diabetes
Interventions
Other: diet following ADA guidelines
Other: vegan diet
Registration Number
NCT01222429
Lead Sponsor
Physicians Committee for Responsible Medicine
Brief Summary

This study aims to test a dietary intervention for diabetes in a medical practice setting, with the aim of developing a model for diabetes care that can be used widely. The investigators hypothesize that a low-fat vegan diet will be effective for management of diabetes and will be feasible in a practice-based setting.

Detailed Description

Specific Aim 1 tests the hypothesis that the nutrition intervention (low fat, low-GI vegan diet) improves glycemic control, body weight, plasma lipid concentrations, blood pressure, and indices of renal function in a within-group analysis.

Specific Aim 2 tests the hypothesis that the nutrition intervention (low fat, low-GI vegan diet) is more effective than standard nutrition care for improving glycemic control, body weight, plasma lipid concentrations, blood pressure, and indices of renal function in individuals with type 2 diabetes

Specific Aim 3 tests the hypothesis that a low-fat vegan diet is sustainable among individuals with type 2 diabetes for a 20-week period, with weekly classes, and in a follow-up period of one year with limited professional support.

Specific Aim 4 tests the hypothesis that a low-fat vegan diet has an acceptability that is comparable to that of standard nutrition care among individuals with type 2 diabetes.

Specific Aim 5 tests the hypothesis that the effects of the dietary interventions on A1c and body weight are reduced in individuals with the A1 allele of the Taq1A and Taq1B polymorphism

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  1. a diagnosis of type 2 diabetes mellitus, as defined by a fasting plasma glucose concentration ≥126 mg/dl on 2 occasions or a prior physician's diagnosis of type 2 diabetes with the use of hypoglycemic medications for at least 6 months
  2. male or female
  3. A1c between 6.5% and 10.5%
  4. age at least 18 years
  5. ability and willingness to participate in all components of the study
  6. willingness to be assigned to either a low-fat, vegan diet or to standard nutrition care
  7. diabetes medications unchanged for 1 month prior to volunteering for the study
  8. patient of Dr. Mark Sklar
Exclusion Criteria
  1. body mass index >45 kg/m2
  2. alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
  3. use of recreational drugs in the past 6 months (past drug use, if fully recovered, is not a criteria for exclusion)
  4. pregnancy or plans to become pregnant
  5. history of severe mental illness (with current unstable status)
  6. likely to be disruptive in group sessions (as determined by research staff)
  7. Signs/symptoms of acute uncontrolled diabetes (including but not limited to polyuria, polydipsia, blurred vision, uncontrolled weight loss)
  8. unstable medical status
  9. already following a low-fat, vegetarian diet
  10. an inordinate fear of blood draws
  11. inability to maintain current medication regimen
  12. lack of English fluency

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
diet following American Diabetes Association guidelinesdiet following ADA guidelinesParticipants will follow diets based on ADA guidelines. This group will also receive weekly nutrition classes.
vegan dietvegan dietParticipants in the intervention group will follow a low-fat, vegan diet for 20 weeks, and will attend nutrition classes in the form of a weekly support group.
Primary Outcome Measures
NameTimeMethod
hemoglobin A1C (diabetes management)assessment at one-year follow-up
lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)assessment at one-year follow-up
body weightassessment at one-year follow-up
indices of renal function (serum creatinine, microalbumin)assessment at one-year follow-up
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath